ARCHIVES

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

This article is from The Cancer Letter archive.

Vol. 17 No. 23 | June 7, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

Five Group Chairs Discuss Mergers In A Q&A

March 11, 2011

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

In Brief: Radiologists Elect Officers, Award Medals; FDA Advisors Okay Test For Breast Cancer

September 29, 1995

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014